Nova Wellness Group Berhad (KLSE:NOVA)
Malaysia · Delayed Price · Currency is MYR 0.3850
0.00 (0.00%)
At close: Oct 30, 2026
KLSE:NOVA Ratios and Metrics
Market cap in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 123 | 107 | 108 | 171 | 220 | 280 | |
Market Cap Growth | 1.32% | -1.47% | -36.45% | -22.46% | -21.36% | 2.94% |
Enterprise Value | 112 | 101 | 105 | 160 | 213 | 258 |
Last Close Price | 0.39 | 0.32 | 0.30 | 0.45 | 0.57 | 0.71 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 14.38 | 12.51 | 14.01 | 21.67 | 14.67 | 17.36 |
Forward PE | 12.83 | 11.24 | 9.29 | 11.81 | 12.52 | 12.10 |
PS Ratio | 2.50 | 2.17 | 2.46 | 4.18 | 4.83 | 5.69 |
PB Ratio | 1.13 | 0.99 | 0.98 | 1.55 | 2.08 | 2.78 |
P/TBV Ratio | 1.19 | 1.04 | 1.04 | 1.65 | 2.22 | 2.78 |
P/FCF Ratio | 8.37 | 7.28 | 47.83 | 35.83 | - | 88.67 |
P/OCF Ratio | 8.19 | 7.13 | 19.47 | 23.58 | 25.06 | 22.79 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 2.29 | 2.06 | 2.38 | 3.93 | 4.68 | 5.25 |
EV/EBITDA Ratio | 9.00 | 8.09 | 9.50 | 14.39 | 11.07 | 13.03 |
EV/EBIT Ratio | 10.47 | 9.41 | 11.15 | 16.65 | 11.86 | 13.84 |
EV/FCF Ratio | 7.66 | 6.88 | 46.32 | 33.73 | - | 81.73 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Debt / Equity Ratio | -0.10 | -0.10 | -0.06 | -0.08 | -0.07 | -0.20 |
Net Debt / EBITDA Ratio | -0.83 | -0.83 | -0.59 | -0.81 | -0.39 | -1.03 |
Net Debt / FCF Ratio | -0.71 | -0.71 | -2.89 | -1.90 | 4.25 | -6.47 |
Asset Turnover | 0.42 | 0.42 | 0.37 | 0.34 | 0.39 | 0.45 |
Inventory Turnover | 1.03 | 1.03 | 0.85 | 0.78 | 0.63 | 0.89 |
Quick Ratio | 9.68 | 9.68 | 6.43 | 6.62 | 4.73 | 6.15 |
Current Ratio | 16.53 | 16.53 | 11.52 | 11.38 | 8.17 | 9.87 |
Return on Equity (ROE) | 7.82% | 7.82% | 7.03% | 7.29% | 14.52% | 16.56% |
Return on Assets (ROA) | 5.73% | 5.73% | 4.93% | 5.07% | 9.72% | 10.73% |
Return on Invested Capital (ROIC) | 7.70% | 7.60% | 6.94% | 6.98% | 15.25% | 20.20% |
Return on Capital Employed (ROCE) | 9.60% | 9.60% | 8.20% | 8.40% | 16.10% | 17.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 6.95% | 7.99% | 7.14% | 4.61% | 6.82% | 5.76% |
FCF Yield | 11.95% | 13.73% | 2.09% | 2.79% | -0.80% | 1.13% |
Dividend Yield | 8.31% | 9.55% | 4.71% | 2.34% | 3.04% | 2.33% |
Payout Ratio | 119.52% | 119.52% | 51.52% | 50.63% | 44.62% | 39.46% |
Buyback Yield / Dilution | - | - | - | 0.04% | -0.34% | -0.01% |
Total Shareholder Return | 8.31% | 9.55% | 4.71% | 2.38% | 2.70% | 2.32% |